Gonadotropin Releasing Hormone Receptor Antagonist
10 drugs across 9 manufacturers|7 Generic,3 Brand
The Gonadotropin Releasing Hormone Receptor Antagonist class contains 10 NDCs from 9 manufacturers (7 generic, 3 brand), at an average NADAC of $54.74 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
10
7G / 3B
Manufacturers
9
Avg $54.7437/unit
Avg 7d Change
0.00%
Across 3 drugs with changes
7d Activity
of 10 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
9 manufacturers producing drugs in this therapeutic class(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate | $62.3467 per ML | — |
FYREMADEL 250 MCG/0.5 ML SYR ganirelix acetate | $62.3467 per ML | — |
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate | $62.3467 per ML | — |
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate | $62.3467 per ML | — |
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate | $62.3467 per ML | — |
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate | $62.3467 per ML | — |
GANIRELIX ACET 250 MCG/0.5 ML Ganirelix Acetate | $62.3467 per ML | — |
MYFEMBREE 40 MG-1 MG-0.5 MG TB relugolix, estradiol hemihydrate, and norethindrone acetate | $45.2544 per EA | +0.03% |
ORILISSA 150 MG TABLET Elagolix | $43.8196 per EA | +0.04% |
ORILISSA 200 MG TABLET Elagolix | $21.9361 per EA | -0.08% |
Frequently Asked Questions
How many drugs are in the Gonadotropin Releasing Hormone Receptor Antagonist class?
The Gonadotropin Releasing Hormone Receptor Antagonist class contains 10 NDCs from 9 manufacturers — 7 generic and 3 brand products.
What is the average price of Gonadotropin Releasing Hormone Receptor Antagonist drugs?
The average NADAC for the Gonadotropin Releasing Hormone Receptor Antagonist class is $54.7437 per unit across 10 NDCs.
Which manufacturers make Gonadotropin Releasing Hormone Receptor Antagonist drugs?
9 manufacturers make drugs in the Gonadotropin Releasing Hormone Receptor Antagonist class. Ranked by number of NDCs, the largest are AbbVie Inc. (2), Amphastar Pharmaceuticals, Inc. (1), Ferring Pharmaceuticals Inc. (1), Fresenius Kabi USA, LLC (1), Lupin Pharmaceuticals Inc. (1).
How has Gonadotropin Releasing Hormone Receptor Antagonist pricing changed recently?
Over the past 7 days, 2 NDCs in this class rose and 1 fell, with a class-wide average change of +0.0%.